Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens

Article Abstract:

An abscess is an area of infected tissue that is swollen with pus and dead tissue. When pelvic infections occur, but are not treated properly, they lead to abscess formation in the female reproductive tract (tuboovarian abscess). This condition can be very serious if left untreated. In the past, before suitable antibiotics were available, this type of abscess was treated surgically, and was associated with high mortality caused by rupture of the abscess. Today, antibiotics, such as clindamycin and metronidazole, are considered to be the best treatment for tuboovarian abscesses. To evaluate the effectiveness of different antibiotics in treating tuboovarian abscesses the following three groups were studied: 37 patients were treated with a combination of cefoxitin and doxycycline (group 1); 64 patients were treated with either clindamycin and tobramycin or clindamycin and gentamicin (group 2); and an additional 18 patients were treated with cefoxitin and doxycycline for two to three days and then switched to clindamycin and tobramycin or clindamycin and gentamicin. Eighty-four percent of those in group 1; 70 percent of those in group 2; and 78 percent of those in group 3 were treated successfully with antibiotic therapy. The rest of the patients required surgery to remove the abscess. The larger abscesses were less likely to respond to treatment with antibiotics and were more likely to require surgery. The results of this study indicate that tuboovarian abscesses can be successfully treated by each of these three antibiotic regimens, and that surgery is not required in all cases. (Consumer Summary produced by Reliance Medical Information, Inc.)

Infection, Drug therapy, Abscess, Fallopian tubes

---

Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis

Article Abstract:

The proliferative phase of the menstrual cycle may predispose women with gonorrhea or chlamydia infection to develop pelvic inflammatory disease. Pelvic inflammatory disease is an infection of the ovaries, Fallopian tubes and uterus. Researchers biopsied the inside of the uterus to determine whether 135 women developed pelvic inflammatory disease. Of these women, 111 had gonorrhea, chlamydia of bacterial vaginosis. Half of the 111 women developed pelvic inflammatory disease compared to only 3 of the 24 women with no sexually transmitted disease. Women in the proliferative phase of the menstrual cycle were 4 times more likely to develop pelvic inflammatory disease.

Health aspects, Risk factors, Gonorrhea, Menstrual cycle, Chlamydia infections, Endometritis

---

Similar abstracts:

• Abstracts: Impetigo: current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Comparison of amoxicillin and clavulanic acid (Augmentin) for the treatment of nonbullous impetigo
• Abstracts: Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus. part 2 An isolated intracardiac echogenic focus as a marker for aneuploidy
• Abstracts: A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function
• Abstracts: Concomitant ganciclovir and zidovudine treatment for cytomegalovirus retinitis in patients with HIV infection: an approach to treatment
• Abstracts: Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. part 2 Human immunodeficiency virus infection in tuberculosis patients

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.